This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Stichting Radboud Universitair Medisch Centrum. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Loek Eggermont: Innovator in Immunomodulatory Nanofilaments
Introduction
Loek Eggermont is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of immunology through his innovative work on nanofilaments that modulate immune responses.
Latest Patents
Loek Eggermont holds a patent for "Immunomodulatory nanofilaments." This invention presents immune factors, particularly cytokines, to immune cells, especially T cells, to modulate their immune response. The patent outlines methods for utilizing these nanofilaments effectively.
Career Highlights
Eggermont is associated with the Radboud University Medical Center, where he conducts research and develops his innovative ideas. His work focuses on enhancing immune responses, which has implications for various medical applications.
Collaborations
He has collaborated with notable colleagues, including Carl Gustav Figdor and Roel Hammink, contributing to advancements in the field of immunology.
Conclusion
Loek Eggermont's work on immunomodulatory nanofilaments represents a significant advancement in immunology, showcasing his innovative spirit and dedication to improving immune response mechanisms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile